Off-label use of quetiapine in New Zealand--a cause for concern? (original) (raw)

This paper discusses the prevalent off-label use of quetiapine among psychiatrists in New Zealand, primarily focusing on its application for anxiety and insomnia. The authors critique the methodology of a Canterbury survey that highlighted the frequency of such off-label prescriptions and analyzed the evidence supporting short-term use for these indications. While acknowledging the commonality of off-label use, they emphasize the importance of informed consent and caution regarding higher doses or long-term usage due to limited supporting data.